Interestingly, in the same study, tumor-related epilepsy at diagnosis also was a predictor of a more favorable survival independent of tumor location and volume, age, KPS score, extent of resection, radiochemotherapy, levetiracetam use and MGMT promotor methylation. Here, MGMT is linked to neoplasm.